Results 31 to 40 of about 3,912,962 (279)

Critical appraisal in rapid systematic reviews of COVID-19 studies: implementation of the Quality Criteria Checklist (QCC)

Systematic Reviews, 2023
In this letter, we briefly describe how we selected and implemented the quality criteria checklist (QCC) as a critical appraisal tool in rapid systematic reviews conducted to inform public health advice, guidance and policy during the COVID-19 pandemic ...
Daphne Duval, Nicola Pearce-Smith, Jennifer C. Palmer, Jason Kwasi Sarfo-Annin, Paul Rudd, Rachel Clark   +5 more
doaj   +1 more source

The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea [PDF]

Osong Public Health and Research Perspectives
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination.
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi   +14 more
doaj   +1 more source

Evaluation of self-administered antigen testing in a college setting

Virology Journal, 2022
Background The objective of our investigation was to better understand barriers to implementation of self-administered antigen screening testing for SARS-CoV-2 at institutions of higher education (IHE).
Sarah C. Tinker, Jessica L. Prince-Guerra, Kelly Vermandere, Jenna Gettings, Cherie Drenzik, Gary Voccio, Tonia Parrott, Jan Drobeniuc, Tonya Hayden, Stephen Briggs, Debbie Heida, Natalie Thornburg, Lisa C. Barrios, John C. Neatherlin, Sabrina Madni, Catherine N. Rasberry, Kenneth D. Swanson, Azaibi Tamin, Jennifer L. Harcourt, Sandra Lester, Lydia Atherton, Margaret A. Honein   +21 more
doaj   +1 more source

COVID-19 Disease and Vaccination: Knowledge, Fears, Perceptions and Feelings of Regret for Not Having Been Vaccinated among Hospitalized Greek Patients Suffering SARS-CoV-2 Infection

Infectious Disease Reports, 2022
Background: The development of vaccines against COVID-19 has greatly altered the natural course of this infection, reducing the disease’s severity and patients’ hospitalization. However, hesitancy against vaccination remains an obstacle in the attempt to
Petros Ioannou, Sotiris Tzalis, Eirini Pasparaki, Despoina Spentzouri, Myrto Konidaki, Ioanna Papakitsou, Nikolaos Spernovasilis, Nikolaos Papanikolaou, George Samonis, Diamantis P. Kofteridis   +9 more
doaj   +1 more source

Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future

Inflammation and Regeneration, 2020
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, and has spread globally to most countries. In Japan, the first COVID-19 patient was identified on January 15, 2020.
Tokio Hoshina, Hiroka Aonuma, Manabu Ote, Tatsuya Sakurai, Erisha Saiki, Yuki Kinjo, Kazuhiro Kondo, Masataka Okabe, Hirotaka Kanuka   +8 more
doaj   +1 more source

Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation model

BMC Public Health, 2022
Background Antigen tests for SARS-CoV-2 offer advantages over nucleic acid amplification tests (NAATs, such as RT-PCR), including lower cost and rapid return of results, but show reduced sensitivity.
Phillip P. Salvatore, Melisa M. Shah, Laura Ford, Augustina Delaney, Christopher H. Hsu, Jacqueline E. Tate, Hannah L. Kirking   +6 more
doaj   +1 more source

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. [PDF]

, 2020
Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or
Greenland, John R, London, Martin J, Michelow, Marilyn D, Wang, Linlin   +3 more
core  

COVID-19 Solution

International Journal of Preventive Medicine, 2020
Coronaviruses (CoV) are RNA viruses that cause endemic infections in various species of mammals and avian birds. There are seven known human CoVs, each of which causes respiratory diseases: together account for about one third of common colds. Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID-19, (CoV), which ...
Roberto Menicagli, Mario Limodio
openaire   +3 more sources

A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom [PDF]

, 2020
Background: In December 2019 the coronavirus disease of 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, was identified in Wuhan, China.
Hunt, Madison, Koziatek, Christian
core  

Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities

BMC Public Health, 2021
Background Shielding of high-risk groups from coronavirus disease (COVID-19) has been suggested as a realistic alternative to severe movement restrictions during the COVID-19 epidemic in low-income countries. The intervention entails the establishment of
Nada Abdelmagid, Salma A. E. Ahmed, Nazik Nurelhuda, Israa Zainalabdeen, Aljaile Ahmed, Mahmoud Ali Fadlallah, Maysoon Dahab   +6 more
doaj   +1 more source